QA: Agile Therapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2019_Agile_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001261249, Agile Therapeutics INC

  xvar xval
0 AssetsCurrent 8,458,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,916,000
3 remainder_Assets 18,000
4 LiabilitiesCurrent 2,218,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,129,147
9 ResearchAndDevelopmentExpense 6,388,538
10 remainder_Expenses 627,977
11 remainder_Revenues 0
12 remainder_NetIncome -1,245,623
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,392,000
1 Liabilities 2,218,000
2 Expenses 15,145,662
3 Revenues 0
4 StockholdersEquity 20,174,000
5 NetIncome -16,391,285
6 ComprehensiveNetIncome -16,391,285
7 BaseVar 20,500,642
8 EconomicCapitalRatiobeforeLimitedLiability 2.24
9 EconomicCapitalRatio 3.19

Edgar->Model Mapping

Feature Distribution

Change over Time